Psilocybin as an Agent for Human and Cultural Development with Jahan Khamsehzadeh Ph.D.
Delving into our Historical and Ancestral Relationship to Psilocybin
Similar Posts
2021: A Year in Review for the Psychedelics Business
Our resident Psychedelic Investor looks back at some of this growing industry’s biggest moments and how they may shape the business in 2022.
Hallucinogen Persisting Perception Disorder Is a Psychedelics Problem Ehave Wants to Solve
“HPPD is a discomfort. Some people have it for 10, 15, 20 years and they regret the day they did the drug that caused it,” says the CEO of Ehave.
DEA Proposes Huge Increase to Psilocybin and Psilocin Quotas for Research Purposes
In its proposed revised 2021 quotas, the DEA suggests 4900% increase in the allowed quantities of psilocybin for research and clinical trial purposes.
Wesana Health’s Dr. ABID NAZEER – The Parallels Between Brain Injury & Addiction (WESA)
Wesana Health’s Dr. ABID NAZEER – The Parallels Between Brain…
How Psychedelic Treatment Through Canada’s SAP Works
Two psychedelic industry insiders reflect on the progress and flaws within Health Canada’s recent amendment to the Special Access Program.
Why the California Governor Vetoed Psychedelic Decriminalization
After passing through the California Assembly and Senate, Governor Gavin Newsom refuses to sign psychedelic decriminalization bill into law.